Literature DB >> 7737914

Human alveolar macrophages augment natural killer cell stimulatory factor (interleukin-12)-inducible killer activity from autologous blood lymphocytes.

T Haku1, S Sone, R Nabioullin, T Ogura.   

Abstract

Interleukin-12 (IL-12), also known as natural killer cell stimulatory factor (NKSF), was found to induce cytotoxic activity from human blood T cells and NK cells. The present study was undertaken to examine the effect of human alveolar macrophages (AM) on induction by IL-12 cytotoxic cells from blood lymphocytes. AM were obtained by bronchoalveolar lavage from healthy donors. Highly purified lymphocytes (> 99%) and monocytes (> 90%) were also isolated by centrifugal elutriation from peripheral blood of the same donors. Cytotoxicity of lymphocytes was measured by 4-h 51Cr release assay. IL-12 stimulated blood lymphocytes to produce interferon gamma (IFN gamma) and tumor necrosis factor alpha (TNF alpha), and this effect was augmented by co-cultivation with monocytes or AM. AM-upregulated induction of cytotoxic lymphocytes was stimulated with IL-12, and this effect was significantly abrogated by addition of antibodies against IFN gamma and TNF alpha. Induction by IL-12 of IFN gamma production and cytotoxic activity of CD8+ cells was also augmented by co-cultivation with monocytes or AM. AM were more effective than monocytes in augmenting the cytotoxic activity of IL-12-stimulated lymphocytes and CD8+ cells. These observations suggest that in situ induction of IL-12-stimulated cytotoxic cells in the lung may be regulated by complex cytokine networks, depending on participation of monocytes and alveolar macrophages.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7737914      PMCID: PMC5920578          DOI: 10.1111/j.1349-7006.1995.tb02991.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  27 in total

Review 1.  Killing of target cells by lymphocytes: a mechanistic view.

Authors:  J D Young
Journal:  Physiol Rev       Date:  1989-01       Impact factor: 37.312

Review 2.  Role of alveolar macrophages in pulmonary neoplasias.

Authors:  S Sone
Journal:  Biochim Biophys Acta       Date:  1986

3.  Interleukin-12 augments cytolytic activity of peripheral blood lymphocytes from patients with hematologic and solid malignancies.

Authors:  R J Soiffer; M J Robertson; C Murray; K Cochran; J Ritz
Journal:  Blood       Date:  1993-11-01       Impact factor: 22.113

4.  Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells.

Authors:  J Chehimi; N M Valiante; A D'Andrea; M Rengaraju; Z Rosado; M Kobayashi; B Perussia; S F Wolf; S E Starr; G Trinchieri
Journal:  Eur J Immunol       Date:  1993-08       Impact factor: 5.532

5.  IL-4 up-regulates IL-1 receptor antagonist gene expression and its production in human blood monocytes.

Authors:  E Orino; S Sone; A Nii; T Ogura
Journal:  J Immunol       Date:  1992-08-01       Impact factor: 5.422

6.  B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes.

Authors:  Y Takai; G G Wong; S C Clark; S J Burakoff; S H Herrmann
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

7.  Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.

Authors:  M Kobayashi; L Fitz; M Ryan; R M Hewick; S C Clark; S Chan; R Loudon; F Sherman; B Perussia; G Trinchieri
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

8.  Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF.

Authors:  M J Robertson; R J Soiffer; S F Wolf; T J Manley; C Donahue; D Young; S H Herrmann; J Ritz
Journal:  J Exp Med       Date:  1992-03-01       Impact factor: 14.307

9.  Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients.

Authors:  J Chehimi; S E Starr; I Frank; M Rengaraju; S J Jackson; C Llanes; M Kobayashi; B Perussia; D Young; E Nickbarg
Journal:  J Exp Med       Date:  1992-03-01       Impact factor: 14.307

10.  Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.

Authors:  A D'Andrea; M Rengaraju; N M Valiante; J Chehimi; M Kubin; M Aste; S H Chan; M Kobayashi; D Young; E Nickbarg
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

View more
  3 in total

1.  Immunological circumvention of multiple organ metastases of multidrug resistant human small cell lung cancer cells by mouse-human chimeric anti-ganglioside GM2 antibody KM966.

Authors:  M Hanibuchi; S Yano; Y Nishioka; H Yanagawa; T Miki; S Sone
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  Induction by interleukin-15 of human killer cell activity against lung cancer cell lines and its regulatory mechanisms.

Authors:  E Takeuchi; H Yanagawa; S Yano; T Haku; S Sone
Journal:  Jpn J Cancer Res       Date:  1996-12

3.  Anti-ganglioside GM2 monoclonal antibody-dependent killing of human lung cancer cells by lymphocytes and monocytes.

Authors:  M Hanibuchi; S Yano; Y Nishioka; H Yanagawa; S Sone
Journal:  Jpn J Cancer Res       Date:  1996-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.